4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001415889-24-026144
Director sold 47,689 shares at $3.72 ($177,403)
- Director acquired 47,689 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Erck Stanley C Director | 2024-11-01 | Option exercise 10b5-1 | +47,689 | $0.04 | $1,908 | 316,807 | D |
| Erck Stanley C Director | 2024-11-01 | Sale 10b5-1 | −47,689 | $3.72 | $177,403 | 269,118 | D |
| Derivatives | |||||||
| Erck Stanley C Director | 2024-11-01 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −47,689 | 0 | D | ||
| Open-market sales · 47,689 sh · avg $3.72 · $177,403 | |||||||
Loading xslF345X05/form4-11052024_041101.xml…